297 related articles for article (PubMed ID: 21473899)
1. Cdk5: multitasking between physiological and pathological conditions.
Lopes JP; Agostinho P
Prog Neurobiol; 2011 Jun; 94(1):49-63. PubMed ID: 21473899
[TBL] [Abstract][Full Text] [Related]
2. [Roles of cyclin-dependent kinase 5 in central nervous system development and neurodegenerative diseases].
Chen J; Wang ZF
Sheng Li Xue Bao; 2010 Aug; 62(4):295-308. PubMed ID: 20717630
[TBL] [Abstract][Full Text] [Related]
3. Peptides derived from Cdk5 activator p35, specifically inhibit deregulated activity of Cdk5.
Kesavapany S; Zheng YL; Amin N; Pant HC
Biotechnol J; 2007 Aug; 2(8):978-87. PubMed ID: 17526058
[TBL] [Abstract][Full Text] [Related]
4. Role of cyclin-dependent kinase 5 in the neurodegenerative process triggered by amyloid-Beta and prion peptides: implications for Alzheimer's disease and prion-related encephalopathies.
Lopes JP; Oliveira CR; Agostinho P
Cell Mol Neurobiol; 2007 Nov; 27(7):943-57. PubMed ID: 17965932
[TBL] [Abstract][Full Text] [Related]
5. An unusual member of the Cdk family: Cdk5.
Dhariwala FA; Rajadhyaksha MS
Cell Mol Neurobiol; 2008 May; 28(3):351-69. PubMed ID: 18183483
[TBL] [Abstract][Full Text] [Related]
6. Cyclin-dependent kinase 5--a neuronal killer?
Guo Q
Sci Aging Knowledge Environ; 2003 Dec; 2003(50):pe36. PubMed ID: 14681576
[TBL] [Abstract][Full Text] [Related]
7. Neuronal cyclin-dependent kinase 5: role in nervous system function and its specific inhibition by the Cdk5 inhibitory peptide.
Kesavapany S; Li BS; Amin N; Zheng YL; Grant P; Pant HC
Biochim Biophys Acta; 2004 Mar; 1697(1-2):143-53. PubMed ID: 15023357
[TBL] [Abstract][Full Text] [Related]
8. p39 Is Responsible for Increasing Cdk5 Activity during Postnatal Neuron Differentiation and Governs Neuronal Network Formation and Epileptic Responses.
Li W; Allen ME; Rui Y; Ku L; Liu G; Bankston AN; Zheng JQ; Feng Y
J Neurosci; 2016 Nov; 36(44):11283-11294. PubMed ID: 27807169
[TBL] [Abstract][Full Text] [Related]
9. Cdk5 acts as a mediator of neuronal cell cycle re-entry triggered by amyloid-beta and prion peptides.
Lopes JP; Oliveira CR; Agostinho P
Cell Cycle; 2009 Jan; 8(1):97-104. PubMed ID: 19158499
[TBL] [Abstract][Full Text] [Related]
10. Special Issue on "Cdk5 and Brain Disorders": Prologue.
Kanungo J
Brain Disord Ther; 2012; Suppl 1():. PubMed ID: 28066692
[TBL] [Abstract][Full Text] [Related]
11. Tale of the Good and the Bad Cdk5: Remodeling of the Actin Cytoskeleton in the Brain.
Shah K; Rossie S
Mol Neurobiol; 2018 Apr; 55(4):3426-3438. PubMed ID: 28502042
[TBL] [Abstract][Full Text] [Related]
12. Three decades of Cdk5.
Pao PC; Tsai LH
J Biomed Sci; 2021 Nov; 28(1):79. PubMed ID: 34814918
[TBL] [Abstract][Full Text] [Related]
13. Physiological and Pathological Roles of Cdk5: Potential Directions for Therapeutic Targeting in Neurodegenerative Disease.
Allnutt AB; Waters AK; Kesari S; Yenugonda VM
ACS Chem Neurosci; 2020 May; 11(9):1218-1230. PubMed ID: 32286796
[TBL] [Abstract][Full Text] [Related]
14. Extraneuronal activities and regulatory mechanisms of the atypical cyclin-dependent kinase Cdk5.
Arif A
Biochem Pharmacol; 2012 Oct; 84(8):985-93. PubMed ID: 22795893
[TBL] [Abstract][Full Text] [Related]
15. Interplay between the p53 tumor suppressor protein family and Cdk5: novel therapeutic approaches for the treatment of neurodegenerative diseases using selective Cdk inhibitors.
Schmid G; Strosznajder JB; Wesierska-Gadek J
Mol Neurobiol; 2006 Aug; 34(1):27-50. PubMed ID: 17003520
[TBL] [Abstract][Full Text] [Related]
16. Focusing on cyclin-dependent kinases 5: A potential target for neurological disorders.
Tian Z; Feng B; Wang XQ; Tian J
Front Mol Neurosci; 2022; 15():1030639. PubMed ID: 36438186
[TBL] [Abstract][Full Text] [Related]
17. The role of CDK5/P25 formation/inhibition in neurodegeneration.
Camins A; Verdaguer E; Folch J; Canudas AM; Pallàs M
Drug News Perspect; 2006 Oct; 19(8):453-60. PubMed ID: 17160145
[TBL] [Abstract][Full Text] [Related]
18. The Role of Cdk5 in Alzheimer's Disease.
Liu SL; Wang C; Jiang T; Tan L; Xing A; Yu JT
Mol Neurobiol; 2016 Sep; 53(7):4328-42. PubMed ID: 26227906
[TBL] [Abstract][Full Text] [Related]
19. Cdk5 regulates multiple cellular events in neural development, function and disease.
Kawauchi T
Dev Growth Differ; 2014 Jun; 56(5):335-48. PubMed ID: 24844647
[TBL] [Abstract][Full Text] [Related]
20. Neurodegeneration in an Abeta-induced model of Alzheimer's disease: the role of Cdk5.
Lopes JP; Oliveira CR; Agostinho P
Aging Cell; 2010 Feb; 9(1):64-77. PubMed ID: 19895631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
